Scientific Opinion on the substantiation of health claims related to plant sterols and plant stanols and maintenance of normal blood cholesterol concentrations (ID 549, 550, 567, 713, 1234, 1235, 1466, 1634, 1984, 2909, 3140), and maintenance of normal prostate size and normal urination (ID 714, 1467, 1635) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

EFSA Journal

Volumn 8, Issue 10, 2010, Pages

[No Author Info available]

Author keywords

blood cholesterol concentrations; health claims; plant stanols; Plant sterols; prostate size; urination

Indexed keywords

EID: 84956625438     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2010.1813     Document Type: Article

References (22)

1. Assouad JL and Piriou Y, 2007. Procyanidins from French maritime pine bark. NUTRAfoods, 6, 25–34.
2. Beer MU, Pritchard H, Belsey EM, and Davidson M, 2001. Effect of a milk drink enriched with increasing doses of free tall oil phytosterols on plasma lipid levels in mildly hypercholesterolemic subjects. Document submitted by Altus Foods to FDA concerning the interim final rule for Vegetable oil sterol esters and coronary heart disease. Docket Nos OOP-1275 and OOP-1276.
3. Berges RR, Windeler J, Trampisch HJ and Senge T, 1995. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet, 345, 1529–1532.
4. Berges RR, Kassen A and Senge T, 2000. Treatment of symptomatic benign prostatic hyperplasia with beta-sitosterol: an 18-month follow-up. British Journal of Urology International, 85, 842–846.
5. Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM and Trautwein EA, 2009. Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. Journal of Nutrition, 139, 271–84.
6. EFSA (European Food Safety Authority), 2008a. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from Unilever PLC/NV on Plant Sterols and lower/reduced blood cholesterol and reduced the risk of (coronary) heart disease. The EFSA Journal, 781, 1–12.
7. EFSA (European Food Safety Authority), 2008b. Scientific Opinion of the Panel on Dietetic Products, Nutrition and Allergies on a request from McNeil Nutritionals Ltd. on plant stanol esters and lower/reduced blood cholesterol and reduced risk of (coronary) heart disease. The EFSA Journal, 825, 1–13.
8. EFSA (European Food Safety Authority), 2009. Scientific Opinion of the Panel on Dietetic Products Nutrition and Allergies on a request from the European Commission and a similar request from France in relation to the authorisation procedure for health claims on plant sterols/stanols and lowering/reducing blood LDL-cholesterol pursuant to Article 14 of Regulation (EC) No 1924/2006. The EFSA Journal, 1175, 1–9.
9. Fischer EA, Jurincic-Winkler CD and Klippel KF, 1993. Conservative treatment of bnign prostatic hyperplasia with high-dosage b-sitosterol (65 mg): results of a placebo-controlled double-blind study. Uroscopy, 1, 12–20.
10. Hendriks HF, Weststrate JA, van Vliet T and Meijer GW, 1999. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition 53, 319–327.
11. Hironaka T, Shroya N, Matsubara H, Matsubara, H, Matsuoka Y and Itakura H, 2006. A double-blind, placebo-controlled study of effects of plant sterol enriched vegetable juice on serum cholesterol concentrations in mildly hypercholesterolemic subjects and safety evaluation. Journal of Oleo Science, 55, 593–606.
12. Ishizaki T, 2003. Effects of long-term intake of mayonnaise containing phytosterolester on blood cholesterol concentration in Japanese with borderline or mild cholesterolemia. Journal of Clinical Biochemistry and Nutrition, 33, 75–82.
13. Kadow C and Abrams PH, 1986. A double-blind trial of the effect of beta-sitosteryl glucoside (WA184) in the treatment of benign prostatic hyperplasia. European Urology, 12, 187–9.
14. Katan MB, Grundy SM, Jones P, Law M, Miettinen T and Paoletti R, 2003. Stresa Workshop Participants, 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings, 78, 965–978.
15. Klippel KF, Hiltl DM and Schipp B, 1997. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. British Journal of Urology, 80, 427–432.
16. Matsuoka R, Masuda, Y, Takeuchi A, Marushima R, Hasegawa M, Sakamoto A, Hirata H, Kajimoto O and Homma Y, 2004. Double-blind, placebo-controlled study on the effects of mayonnaise containing free plant sterol on serum cholesterol concentration; safety evaluation for normocholesterolemic and mildly hyercholesterolemic Japanese subjects. Journal of Oleo Science, 53, 79–88.
17. Miettinen TA and Vanhanen H, 1994. Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis, 105, 217–226.
18. Niittynen LH, Jauhiainen TA, Poussa TA and Korpela R, 2007. Effects of yoghurt enriched with free plant sterols on the levels of serum lipids and plant sterols in mildly hypercholesterolaemic subjects on a high-fat diet. International Journal of Food Sciences and Nutrition, 18, 1–11.
19. Sierksma A, Weststrate JA and Meijer GW, 1999. Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols and plasma total- and LDL-cholesterol concentrations. British Journal of Nutrition, 82, 273–282.
20. Vanhanen H, 1994. Cholesterol malabsorption caused by sitostanol ester feeding in pravastatin-treated hypercholesterolaemic patients. European Journal of Clinical Pharmacology, 47, 169–176.
21. Wilt TJ, MacDonald R and Ishani A, 1999. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. British Journal of Urology International, 83, 976–983.
22. Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C and Lau J, 2000. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev, CD001043.